healthneutral

Weight Loss Wins: Five Years of Diabetes Relief and Money Saved

United Kingdom, SheffieldSunday, March 29, 2026

Program Overview

  • Name: Counterweight‑Plus
  • Origin: DiRECT diabetes trial
  • Duration studied: 5 years

Key Findings

Metric Value
Average weight loss 6.1 kg
% no longer on medication 10%

Economic Impact

  • Long‑term savings from reduced drug use, fewer hospital visits, and lower complication rates.
  • Despite extra coaching, diet plans, and monitoring time, the program remains cheaper than standard treatments.
  • Savings stem from both lower medical bills and the intrinsic value of healthier, longer lives.

Implications

  • Investing in sustained weight‑loss programs can benefit patients and insurers alike.
  • The evidence supports that a modest, maintained weight loss reduces the overall burden of type 2 diabetes.

Actions